PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 83 filers reported holding PRINCIPIA BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,075,000 | +66.2% | 17,982 | +65.1% | 0.01% | +25.0% |
| Q1 2020 | $647,000 | +2.5% | 10,892 | -5.5% | 0.00% | +100.0% |
| Q4 2019 | $631,000 | +164.0% | 11,521 | +36.2% | 0.00% | +100.0% |
| Q3 2019 | $239,000 | -15.5% | 8,457 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $283,000 | +128.2% | 8,516 | +133.8% | 0.00% | – |
| Q1 2019 | $124,000 | +20.4% | 3,642 | -3.1% | 0.00% | – |
| Q4 2018 | $103,000 | – | 3,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 401,046 | $23,814,000 | 13.70% |
| BVF INC/IL | 1,583,595 | $94,034,000 | 8.76% |
| Sofinnova Investments, Inc. | 1,417,258 | $84,157,000 | 7.78% |
| New Leaf Venture Partners, L.L.C. | 422,214 | $25,071,000 | 7.50% |
| Cormorant Asset Management, LP | 2,100,000 | $124,698,000 | 5.79% |
| Redmile Group, LLC | 2,261,088 | $134,263,000 | 3.76% |
| Consonance Capital Management LP | 689,718 | $40,955,000 | 3.05% |
| EAM Global Investors LLC | 43,369 | $2,575,000 | 1.51% |
| EAM Investors, LLC | 61,831 | $3,672,000 | 1.14% |
| Woodline Partners LP | 242,776 | $14,416,000 | 1.03% |